To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Criminal Justice, Government Operations.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H805CABB14D5C447C8AB27BEED81DF926: 1. Preterm infant formula The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall study— the availability of...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Criminal Justice, Government Operations
Primary Purpose
This bill, To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMrs. Harshbarger (for herself and Mr. Schneider) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
any infant formula that is exempt under section 412(h)(1) of the Federal Food Drug, and Cosmetic Act (21 U.S.C. 350a(h)) and intended to be administered to— an infant born before 37 weeks of gestation
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology